Noevir Holdings Co Ltd
TSE:4928
Noevir Holdings Co Ltd
Cash & Cash Equivalents
Noevir Holdings Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Noevir Holdings Co Ltd
TSE:4928
|
Cash & Cash Equivalents
¥24.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-4%
|
|
Shiseido Co Ltd
TSE:4911
|
Cash & Cash Equivalents
¥90.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Cash & Cash Equivalents
¥89.2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Cash & Cash Equivalents
¥47.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
3%
|
|
Kao Corp
TSE:4452
|
Cash & Cash Equivalents
¥245.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Cash & Cash Equivalents
¥62.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
See Also
What is Noevir Holdings Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
24.8B
JPY
Based on the financial report for Dec 31, 2023, Noevir Holdings Co Ltd's Cash & Cash Equivalents amounts to 24.8B JPY.
What is Noevir Holdings Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-4%
Over the last year, the Cash & Cash Equivalents growth was 3%. The average annual Cash & Cash Equivalents growth rates for Noevir Holdings Co Ltd have been -1% over the past three years , and -4% over the past ten years .